Did you know this truth about HbA1c?
Two-Year Results Support Use of Canagliflozin in the Elderly
Long-term use of this SGLT2 inhibitor revealed sustained clinical benefits in older patients with diabetes and most AEs reported were mild.
5 Things You Need to Know About SGLT2-I Use in the Elderly
SGLT2 inhibitors perform well in older patients and cause minimal hypoglycemia. But caution is advised and here are 5 reasons why.
GLP-1 Receptor Agonist Approved for Weight Control
Liraglutide 3 mg (Saxenda) is approved for use in adults with BMI >30 or with BMI >27 and one significant obesity-related condition.
GLP-1 Agonist, Basal Insulin Powerful Against T2DM
A recent meta-analysis found that patients treated with a combination of a GLP-1 agonist and basal insulin had a significantly greater A1c reduction than patients on any other treatment regimen.
Top 10 Endocrinology Apps
Endo Tools, Endo Pubs, Glooko--just a few of the mobile apps described here, all designed specifically for the clinical endocrinologist.
Truths About HbA1c
In the international diabetes community the topic of hemoglobin A1c (HbA1c) continues to generate controversy for a number of reasons.
Diabetes and GI Woes
Three-quarters of persons with diabetes will experience significant gastrointestinal symptoms. What underlies the evolution of these GI ailments?
By clicking Accept, you agree to become a member of the UBM Medica Community.